On September 20, 2024, the Food and Drug Administration sanctioned isatuximab-irfc (Sarclisa, Sanofi-Aventis U.S. LLC) in conjunction with bortezomib, lenalidomide, and dexamethasone for people with...
July 2024: The Food and Drug Administration (FDA) has granted approval for the use of daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Research & Development, LLC) in conjunction with ...
Zevor-Cel therapy Chinese regulators have approved zevorcabtagene autoleucel (zevor-cel; CT053), an autologous CAR T-cell therapy, for the treatment of adult patients with multiple myeloma that has r...
Introduction Even in transplant-eligible (TE) patients, typical first-line treatments for high-risk (HR) newly-diagnosed multiple myeloma (NDMM) have dismal outcomes. A high-efficacy, safe CAR-T trea...
Blood cancer is a type of cancer that affects both the blood and bone marrow. It is the fifth most common type of cancer in the world, with around 1.24 million new cases diagnosed each year. Wonderin...
FUCASO treatment in China The overall response rate of this revolutionary cancer therapy named FUCASO is 96%. The NMPA's approval marks a turning point in China's fight against multiple myeloma. Th...
Free cancer treatment in China is providing hope and healing to people in need. So, if you are unable to opt for cancer treatment because of its extensive cost, this guide is specially meant for you...
Read our guide to learn about the silent indicators of multiple myeloma. Learn to spot them early, so you can make smart choices for your health. Don't ignore the warning signs, empower yourself ...
Learn about the different stages and types of multiple myeloma. Find hope and support with information on treatments and coping strategies. This simple guide can help you take charge of your health a...
Curious about how a medical technique is saving the lives of multiple myeloma patients? Read our blog to learn more about this life-saving technique! Let's turn the page on cancer together. Your stor...